Concepedia

Author

Jyoti Jaju

World Health Organization - India

Also Known As

J. Jaju, Jyoti Jaju, Mallik Parmar

18

Publications

287

Citations

9

H-Index

9

Concepts

All Affiliations

World Health Organization - IndiaMinistry of Health and Family WelfareGovernment of Andhra PradeshGovernment of IndiaNational Institute of Research in Tuberculosis
JJ

About

Jyoti Jaju is an author at World Health Organization - India specializing in drug resistance, pharmacotherapy, and tuberculosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

31

2

Pharmacology

1

1

31

3

Drug Resistance

1

1

31

4

Preventive Medicine

1

1

31

5

Tuberculosis

1

1

31

Jyoti Jaju

×

8

Publications

246

Citations

8

H-Index

YearCitations

Tuberculosis Management Practices by Private Practitioners in Andhra Pradesh, India

Shanta Achanta, Jyoti Jaju, Ajay Kumar,

PLoS ONE

2013

52

Screening tuberculosis patients for diabetes in a tribal area in South India

Shanta Achanta, Rama Rao Tekumalla, Jyoti Jaju,

Public Health Action

2013

43

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population

Neeraj Raizada, Kuldeep Singh Sachdeva, Soumya Swaminathan,

PLoS ONE

2015

33

Feasibility and Effectiveness of Provider Initiated HIV Testing and Counseling of TB Suspects in Vizianagaram District, South India

Shanta Achanta, Ajay Kumar, Sharath Burugina Nagaraja,

PLoS ONE

2012

31

Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis

Virender Singh Salhotra, K.S. Sachdeva, Neelima Kshirsagar,

Indian Journal of Tuberculosis

2019

31

The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India

Dorai Deepa, Shanta Achanta, Jyoti Jaju,

PLoS ONE

2013

28

How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?

Sharath Burugina Nagaraja, Srinath Satyanarayana, Sarabjit Chadha,

PLoS ONE

2011

14

Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial

Chandrasekaran Padmapriyadarsini, Vikas Oswal, Chetankumar D Jain,

Clinical Infectious Diseases

2024

14

Page 1